BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15956444)

  • 1. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.
    Van Daele S; Verhelst R; Claeys G; Verschraegen G; Franckx H; Van Simaey L; de Ganck C; De Baets F; Vaneechoutte M
    J Clin Microbiol; 2005 Jun; 43(6):2998-3002. PubMed ID: 15956444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.
    Wellinghausen N; Wirths B; Poppert S
    J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid genotyping of Achromobacter xylosoxidans, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates using melting curve analysis of RAPD-generated DNA fragments (McRAPD).
    Deschaght P; Van Simaey L; Decat E; Van Mechelen E; Brisse S; Vaneechoutte M
    Res Microbiol; 2011 May; 162(4):386-92. PubMed ID: 21320595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.
    Lambiase A; Catania MR; Del Pezzo M; Rossano F; Terlizzi V; Sepe A; Raia V
    Eur J Clin Microbiol Infect Dis; 2011 Aug; 30(8):973-80. PubMed ID: 21279730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
    Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
    BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.
    Hafiane A; Ravaoarinoro M
    Pathol Biol (Paris); 2011 Oct; 59(5):e109-14. PubMed ID: 19896303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.
    Magni A; Trancassini M; Varesi P; Iebba V; Curci A; Pecoraro C; Cimino G; Schippa S; Quattrucci S
    J Clin Microbiol; 2010 Apr; 48(4):1035-9. PubMed ID: 20107101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.
    Pereira RH; Carvalho-Assef AP; Albano RM; Folescu TW; Jones MC; Leão RS; Marques EA
    J Clin Microbiol; 2011 Oct; 49(10):3649-51. PubMed ID: 21849686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Achromobacter xylosoxidans by detection of the bla(OXA-114-like) gene intrinsic in this species.
    Turton JF; Mustafa N; Shah J; Hampton CV; Pike R; Kenna DT
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):408-11. PubMed ID: 21497041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India.
    Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN
    Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the efficacy of real-time polymerase chain reaction for the routine early detection of Pseudomonas aeruginosa in cystic fibrosis sputum and throat swab specimens.
    Logan C; Habington A; Lennon G; Cronin F; O'Sullivan N
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):358-65. PubMed ID: 20884156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre.
    Van Daele SG; Franckx H; Verhelst R; Schelstraete P; Haerynck F; Van Simaey L; Claeys G; Vaneechoutte M; de Baets F
    Eur Respir J; 2005 Mar; 25(3):474-81. PubMed ID: 15738291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Giordano A; Magni A; Graziani C; Sessa R; Quattrucci S; Cipriani P
    New Microbiol; 2001 Apr; 24(2):157-63. PubMed ID: 11346299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achromobacter xylosoxidans isolated from the sputum of a patient with cystic fibrosis mutation I1234V with Pseudomonas aeruginosa.
    Abdul Wahab A; Janahi IA; El-Shafie SS
    Saudi Med J; 2004 Jun; 25(6):810-1. PubMed ID: 15195220
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis.
    Mathy V; Grohs P; Compain F
    J Med Microbiol; 2018 Sep; 67(9):1217-1220. PubMed ID: 30016231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
    Krzewinski JW; Nguyen CD; Foster JM; Burns JL
    J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis].
    Moissenet D; Bingen E; Arlet G; Vu-Thien H
    Pathol Biol (Paris); 2005; 53(8-9):500-2. PubMed ID: 16081224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.